Ok Biotech Co Stock EBITDA
4155 Stock | 26.80 0.75 2.72% |
Ok Biotech Co fundamentals help investors to digest information that contributes to Ok Biotech's financial success or failures. It also enables traders to predict the movement of 4155 Stock. The fundamental analysis module provides a way to measure Ok Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ok Biotech stock.
4155 |
Ok Biotech Co Company EBITDA Analysis
Ok Biotech's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Ok Biotech EBITDA | 110.1 M |
Most of Ok Biotech's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ok Biotech Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition |
According to the company disclosure, Ok Biotech Co reported earnings before interest,tax, depreciation and amortization of 110.1 M. This is 87.45% lower than that of the Healthcare sector and 82.86% lower than that of the Medical Devices industry. The ebitda for all Taiwan stocks is 97.18% higher than that of the company.
4155 EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ok Biotech's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ok Biotech could also be used in its relative valuation, which is a method of valuing Ok Biotech by comparing valuation metrics of similar companies.Ok Biotech is currently under evaluation in ebitda category among related companies.
4155 Fundamentals
Return On Equity | 0.0799 | |||
Return On Asset | 0.0155 | |||
Profit Margin | 0.1 % | |||
Operating Margin | 0.05 % | |||
Current Valuation | 3.01 B | |||
Shares Outstanding | 95.67 M | |||
Shares Owned By Insiders | 23.77 % | |||
Shares Owned By Institutions | 0.47 % | |||
Price To Book | 1.49 X | |||
Price To Sales | 1.71 X | |||
Revenue | 1.26 B | |||
Gross Profit | 186.83 M | |||
EBITDA | 110.1 M | |||
Net Income | 43.46 M | |||
Total Debt | 401.76 M | |||
Book Value Per Share | 18.46 X | |||
Cash Flow From Operations | 21.9 M | |||
Earnings Per Share | 1.34 X | |||
Beta | 0.38 | |||
Market Capitalization | 3.21 B | |||
Total Asset | 2.81 B | |||
Z Score | 4.2 | |||
Annual Yield | 0.03 % | |||
Net Asset | 2.81 B | |||
Last Dividend Paid | 1.0 |
About Ok Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ok Biotech Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ok Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ok Biotech Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ok Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ok Biotech's short interest history, or implied volatility extrapolated from Ok Biotech options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ok Biotech Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for 4155 Stock analysis
When running Ok Biotech's price analysis, check to measure Ok Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ok Biotech is operating at the current time. Most of Ok Biotech's value examination focuses on studying past and present price action to predict the probability of Ok Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ok Biotech's price. Additionally, you may evaluate how the addition of Ok Biotech to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |